并且帮助客户去增加价值的这种能力。这又是一个它难以被超越的这么一个关键的点。那还有一个就是亚洲科技其实很早就理解了,那在做行业部署的过程中需要对各个行业有深刻的理解。这也为什么过去,应该是几年前吧,就收购了二维咨询。 艾瑞咨询这家公司我想大家应该都比较了解它对行业的这种咨询过程中积累的行业的数据对行业特点的把握也是为亚信科技在未来具备从事各行各业行业大模型开发交付做部署能够提供这个行业的积累和积淀以上的这三个点我觉得就形成了亚信科技 明明说我是亚新安全董秘王非常感谢各位投资者在周日的下午抽出时间参加我们亚新安全亚新科技的联合电话会关注公司的投资者应该了解我们在去年11月公司完成了对亚新科技的收购实现了并表我们两家公司重新成为了一家人 其实很多的投资者对我们双方的合作认知还存在很大的一个认知差所以在今天开始这个阶段我也想简单的跟大家聊一聊在大模型部署交付这一块科技和亚新安全两家公司独特的商业模式这也是我跟很多投资者在私下交流过程中也深切感受到很多人并不了解我们的优势在哪 都反复的在问未来我们的竞争对手对我们形成的冲击会不会对我们目前的优势产生一个实质性的影响在这个地方呢我也想一并的做出一个回应并说一下我个人对两 ...

Summary of China Resources Sanjiu's Conference Call Company Overview - **Company**: China Resources Sanjiu - **Industry**: Pharmaceutical and Health Products Key Financial Performance - Revenue growth from 13.6 billion to 24.7 billion from 2020 to 2023, with a compound annual growth rate (CAGR) of 19% [3] - Net profit increased from 1.6 billion to 2.85 billion during the same period, with a CAGR of 21% [3] - For the first three quarters of 2024, revenue reached 19.7 billion and net profit was 2.96 billion [3] Core Business and Market Performance - Core businesses include Consumer Health Care (CHC) and Prescription Drugs (RIX) [4] - CHC revenue grew from 7.56 billion to 11.7 billion from 2019 to 2023, with a CAGR of 12%, accounting for 52% of total revenue in the first half of 2024 [4] - The leading product, 39 Cold Granules, achieved a market share of 23% with retail sales of 3.08 billion in 2023 [5] Research and Development (R&D) Investment - R&D investment increased from 530 million to 890 million from 2019 to 2023, with a CAGR of 14% [6] - R&D personnel grew from over 400 to 778, with a CAGR of 18% [6] - 112 ongoing projects focused on oncology, orthopedics, and other therapeutic areas [6] Mergers and Acquisitions - Significant acquisitions include Kunming Pharmaceutical Group and Tianjin Tasly, enhancing product lines and capabilities in cardiovascular fields [7] - The acquisition of Kunming Pharmaceutical significantly contributed to the company's traditional Chinese medicine segment [7] Shareholder Returns - Increased dividend payout ratio, with 2021 dividends at 8.6 per 10 shares, maintaining above 10 per 10 shares thereafter [8] - Implementation of an equity incentive plan to motivate mid-to-senior management [8] Future Development Strategy - Focus on both organic growth and strategic acquisitions to enhance market share [9] - Increased R&D investment to strengthen innovation capabilities [9] Prescription Drug Business Outlook - Prescription drug revenue declined by 13.2% to 5.2 billion in 2023 due to regulatory changes and procurement policies [12] - The company aims to recover through innovation and cost management strategies [12] Financial Projections - Expected revenue growth of over 10% from 2024 to 2026, with net profits projected at 3.37 billion, 3.84 billion, and 4.35 billion respectively [14] - Earnings per share (EPS) forecasted at 2.62, 2.99, and 3.39 for the same period [14] Valuation and Risks - Target price set at 56.8 based on a 19x PE ratio for 2025 [15] - Risks include intensified market competition, integration challenges, goodwill impairment, and uncertainties from procurement policies and raw material price fluctuations [15]

中信证券 两会政策对大类资产的影响（策略&固定收益） 20250305 摘要 政府工作报告在具体政策上有哪些亮点？ 报告在具体政策上有几个亮点。首先，在消费和投资方面，提出了消费的提振 专项行动，并计划通过 3,000 亿特别国债进行以旧换新。此外，还提出提高投 资效益，包括 7,350 亿中央投资项目。在产业政策上，将主要产业分为三类： 新兴产业、未来产业、传统制造业，以及数字经济。近期资本市场热衷的新兴 和未来产业如低空商业航天、低空经济及数字经济中的 AI+等都被重点提及。 今年（2025 年）的宏观经济目标是什么？如何实现这些目标？ Q&A 请您总结一下今年（2025 年）政府工作报告的核心特点和政策取向。 今年（2025 年）的政府工作报告可以分为需求和供给两端。从需求端来看，主 要内容是更加积极有为的宏观政策，特别强调了"能早尽早"和"宁早勿晚"， 这与去年（2024 年）的政策节奏有所不同。此外，还提到了民生导向，特别关 • 2025 年政府工作报告设定经济增长目标为 5%，通胀目标为 2%，强调逆周 期调节，财政融资规模达 11.86 万亿，若包含专项债则接近 13.86 万亿， 占 GDP ...

除 TYK2 抑制剂外，益方生物还有 URAT1 抑制剂 Rednone，用于痛风治疗。今年 （2025 年），Rednone 迎来确定性提升时刻，包括海外联用数据及国内二期临 床试验数据可能披露。因此，在投资益方生物时，需要关注这两个关键资产： TYK2 抑制剂和 URAT1 抑制剂。 益方生物 20250305 摘要 Q&A 创新药行业的投资机会和趋势是什么？ 创新药行业的投资机会具有较强的产业趋势，主要体现在商业化变现模式上。 首先，从国内市场来看，以 A 股创新药公司为例，大约有 26 家公司在过去及未 • 百济神州带动创新药板块表现突出，预计 2024-2026 年板块维持 25%-40% 增速，利润端亏损大幅收窄，行业利润端预计 2026 年实现盈利，出海模式 通过出售海外权益实现商业化变现趋势增强，2024 年全球 BD 交易总额约 600 亿美金，2025 年前两月已达 100 亿美金，中国公司占比提升。 • 益方生物核心资产 TYK2 抑制剂用于银屑病治疗，二期临床数据在同靶点药 物中表现最佳，具 best in class 潜力，欧美市场同类药物通常占据高市 占率，商业价值巨大。银屑病治疗 ...

Summary of Key Points from Conference Call Records Industry or Company Involved - The conference call records primarily discuss the implications of the government work report on various industries, including real estate, food and beverage, construction, new energy, technology, and transportation. Core Insights and Arguments - **Government Work Report Focus**: The report emphasizes the importance of timely policy implementation, with a focus on early action to address uncertainties. The GDP growth target remains unchanged, while the CPI target is adjusted down to around 2% to stabilize prices through supply-demand optimization [2][2][2]. - **Real Estate Sector Support**: The report maintains a positive stance towards the real estate sector, detailing measures such as lifting restrictions, urban village renovations, and improving financing mechanisms to support the market [2][9][10]. - **Consumer Confidence in Food and Beverage**: The white liquor sector is expected to benefit from improved economic conditions, with a correlation to business activities. The report indicates that PPI is likely to rebound, positively impacting the liquor industry's sales [2][13][13]. - **Construction Industry Guidance**: The report outlines an increase in special bonds by 500 billion, with a total of 1.3 trillion in long-term special bonds issued, indicating a significant boost in fiscal spending for the construction sector [2][14][14]. - **New Energy Sector Growth**: The new energy industry is expected to benefit from dual carbon goals and the potential for consumption upgrades. Lithium battery prices are rising, driven by increased demand from electric vehicle sales [2][19][19]. - **Technology Sector Opportunities**: The technology sector is experiencing significant changes, with a focus on AI and digital technology integration. Companies like ByteDance and Huawei are highlighted for their advancements in AI applications [2][5][5]. - **Transportation Sector Development**: The report emphasizes the growth of the low-altitude economy and commercial aerospace as emerging industries, with specific regions identified for development [2][28][28]. Other Important but Potentially Overlooked Content - **Market Dynamics**: The A-share market is expected to remain stable, with no immediate significant impact from the government work report. However, April is identified as a critical month for observing economic data and potential rebounds in cyclical sectors [4][4]. - **Investment Recommendations**: The report suggests focusing on sectors like construction, new energy, and technology for potential investment opportunities, while also monitoring the performance of leading companies in these areas [2][18][18]. - **Long-term Trends**: The government work report indicates a commitment to long-term structural reforms in capital markets, including enhancing the role of strategic funds and optimizing the stock issuance process [2][25][25]. This summary encapsulates the key insights and implications from the conference call records, providing a comprehensive overview of the current market landscape and future opportunities across various sectors.

泰恩康 20250305 摘要 Q&A • 泰恩康 2021 年以来财务受疫情和核心产品供应限制影响，但整体费用率和 利润率相对稳定。药品类业务占比高，两性健康板块和和胃整肠丸贡献主 要毛利，前者毛利率超 90%，后者超 80%。 • 和胃整肠丸是泰恩康独家 OOPC 产品，2023 年获得全套生产技术，推进国 产化以解决供应问题。国产化后，成本降低将提升毛利率，自主生产所得 税低于代理模式，且产能限制解除后可扩大市场份额。 • 泰恩康中成药国产化项目进展缓慢，因国内无先例，审批需与 CDMO 反复沟 通。预计 2025 年上半年取得进展，国产化后将显著降低成本，提升毛利率， 并扩大市场份额。 • 白癜风创新药 CKBA 软膏（CTK）为 1.1 类新药，二期临床试验预计 2025 年 6 月公布数据，早期数据疗效良好。白癜风市场潜力大，现有治疗方案副 作用大，CTK 有望拓展至其他皮肤病或自免疾病适应症。 • 毛果芸香碱滴眼液用于治疗老花眼，国内无同类产品上市，已完成三期临 床试验，有望近期申报上市，具有先发优势。复方硫酸钠片剂用于替代聚 乙二醇电解质溶液，已报产，改善患者体验。 • 泰恩康预计 2025 ...

Summary of Fuda Co., Ltd. Conference Call Company Overview - Fuda Co., Ltd. primarily focuses on automotive power systems and transmission system components, including crankshafts, gears, and clutches [3][5] - The company has established strong relationships with leading clients such as BYD, Seres, Ideal, and Chery, contributing to sustained high growth [3][5] Financial Projections - Expected net profits for 2024, 2025, and 2026 are projected to be 170 million, 280 million, and 390 million CNY respectively, with a compound annual growth rate (CAGR) exceeding 50% [3][12] - Revenue targets for 2025 and 2026 are set at 2.67 billion and 3.48 billion CNY, with year-on-year growth rates of 58% and 30% respectively [3][13] Market Dynamics - Fuda benefits from the increasing penetration of the new energy vehicle (NEV) market, particularly in hybrid and extended-range models, driven by demand from major clients [3][8] - The crankshaft market is evolving, with more independent brands sourcing from third-party suppliers, benefiting Fuda as a leading enterprise [8] Competitive Advantages - Fuda possesses vertical integration capabilities, controlling the entire production process from forging to finished products, which enhances cost control and profitability [3][5][11] - The gross margin for crankshaft processing is close to 25%, with an overall profit margin of approximately 11% [3][5] Strategic Initiatives - The company is actively expanding into the core components of robotics, particularly focusing on planetary gear reducers, leveraging existing client relationships [3][4][12] - Fuda's new energy electric drive gear business is entering a growth phase, with revenue targets set at 25 million, 160 million, and 300 million CNY for 2024 to 2026 [3][10] Ownership Structure - Fuda is a family-owned enterprise controlled by the Li family, which holds 58.1% of the shares, ensuring stable strategic execution [7] Industry Trends - The domestic crankshaft market demand is stable at around 8 billion CNY, with a unit value of approximately 400 CNY per vehicle [8] - The shift towards new energy vehicles is leading to increased reliance on third-party suppliers, enhancing Fuda's market position [8] Valuation and Investment Rating - Fuda's estimated price-to-earnings (PE) ratio is approximately 23 times for 2025 and 17 times for 2026, which is competitive compared to peers [13][14] - Given the company's strong growth prospects and potential in the machinery sector, an initial buy rating has been assigned [14]

对话专家：2025，人形机器人产业加速 20250305 摘要 Q&A DeepSeek 大模型对机器人行业，特别是机器智能方面有哪些影响？ DeepSeek 作为单模态的大模型，其主要进展在于算法优化和速度提升，以及知 识蒸馏的应用。DeepSeek 在中文处理能力上优于 ChatGPT，因为其训练数据集 中包含更多的中文样本。这使得 DeepSeek 在国内高校和政府部门中得到广泛部 署，对行业产生了积极推动作用。人工智能的新阶段被称为聚生智能，即赋予 人工智能一个身体。传统的单模态模型，如象棋程序或文本生成模型，无法满 足机器人的需求。机器人需要多模态模型，这些模型必须处理来自互联网、合 成数据和物理世界的数据。这三类数据集结合起来，为研究具身智能和人形机 器人提供了必要的数据基础。 目前国内外在人形机器人技术水平上有哪些差异？技术路径有何不同？ 国内外在人形机器人技术水平上存在一定差异。目前，国外资本对中国科技创 新的兴趣逐渐增加，这也带动了国内资本市场的发展。在技术路径方面，国内 • 人形机器人技术国内外存在差异，国内企业更注重结合大模型与实际应用， 国外则侧重基础研究。资本对中国科技创新兴趣增加， ...

中信证券 工程机械版块近况跟踪&重点公司推荐（机械） 20250305 摘要 Q&A 2025 年国内工程机械行业的市场表现如何？ 2025 年国内工程机械行业的开局表现超出预期。2 月挖掘机内销预计达到 1 万 台以上，相比 2024 年 2 月的 5,837 台，同比增速约为 70%。1-2 月合并来看， 内销同比增速预期在 30%-40%之间。3 月内销情况依旧乐观，预计销量将冲刺至 2 万台，而 2024 年 3 月为 15,000 多台，占全年内销排量的 16%-17%。全年挖掘 • 柳工预计 2025 年 3 月国内挖掘机销量将达 2 万台，同比增长约 30%，受益 于新农村建设、高标准农田建设和水利工程等需求驱动，全年销量目标为 12 万-13 万台，同比增长 20%-30%。 • 柳工设定了清晰的盈利目标，计划到 2027 年实现 500 亿人民币收入，净利 率达到 8%，对应净利润约 40 亿人民币，若按 15 倍 PE 估值，远期市值可 达 600 亿人民币，较目前 260 亿人民币市值有显著增长空间。 • 柳工在电动产品领域取得进展，电装产品在欧洲市场反馈良好，受益于欧 美市场电装产品高 ...

Summary of the Conference Call on the Jewelry Industry and Chao Hong Ji Company Overview - Chao Hong Ji is positioned as a mid-to-high-end fashion consumer brand operator, with key brands including Chao Hong Ji and Fan Di, as well as the handbag brand Fei An Ni acquired in 2012 [3][4][10] - The core customer demographic is fashion-conscious women aged 25 to 35 [3][4] Financial Performance - From 2018 to 2024, the number of franchise stores increased from 337 to nearly 1,200, while self-operated stores decreased from 570 to approximately 250 [3][4] - In the first three quarters of 2024, revenue grew by about 8% year-on-year, and net profit attributable to shareholders remained stable, outperforming the industry average [4] - Despite a slight decline in gross margin, the continuous optimization of expense ratios has led to stable profit margins, with expectations for further improvement in 2025 [4][10] - The company anticipates a revenue of approximately 420-430 million in 2025, corresponding to a valuation of around 15 times [11] Market Trends and Consumer Behavior - The jewelry industry is experiencing a shift from material value to aesthetic design and storytelling marketing, driven by a younger target audience and a shift in luxury consumption [8] - As of February 2025, gold prices rose by 6% year-on-year, with high-end markets performing better than mid-range markets during the Spring Festival [5][7] - Sales during the Spring Festival increased by about 10% year-on-year, but excluding the impact of rising gold prices, sales volume decreased by 10%-15% [5][7] Strategic Initiatives - Chao Hong Ji is focusing on expanding its franchise model, with a lighter store model that has a standard opening cost of approximately 5 million, lower than competitors [10] - The company plans to maintain around 150 stores, targeting a growth rate of about 10% [10] - The introduction of new products in the spring is expected to drive growth, especially in a year with increased wedding demand [7][8] Competitive Landscape - The jewelry industry is seeing a divergence in performance among brands, with leading brands like Zhou Da Sheng experiencing a decline of over 20% in same-store sales, while Chao Hong Ji benefited from high conversion rates and significant contributions from its popular products [5][9] - The company has successfully launched standout products, such as the "繁华系列" bracelet, which has significantly contributed to sales [9] Future Outlook - There is potential for increasing franchise fees, with the company having raised fees for fixed-price products from 3% to 6% in April 2023 [11] - The overall market conditions and company performance in the first quarter of 2025 are expected to provide a positive outlook for revenue and profit growth [11]